English | Español
Michael McGrady | Jun 8, 2017

American Medical Association applauds Anthem-Cigna merger rejection

Michael McGrady | Jun 7, 2017

Federal agencies weigh in on Zika outbreak response
Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Carrice Quinnie | Jun 4, 2017

Merck enters exclusive license agreement with Teijin Pharma
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting
Robert Hadley | Jun 4, 2017

Merck’s targeted tumor drug approved for colorectal and other cancers
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley | Jun 2, 2017

FDA approves higher once-a-day dose of Merck’s Isentress HIV drug 

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’